Risk factors for chronic renal dysfunction in cardiac allograft recipients

被引:33
作者
Esposito, C
Semeraro, L
Bellotti, N
Fasoli, G
Fornoni, A
Rampino, T
Klersy, C
Campana, C
Gavazzi, A
Viganò, M
Dal Canton, A
机构
[1] Univ Pavia, IRCCS, Policlin San Matteo, Dept Internal Med & Nephrol, I-27100 Pavia, Italy
[2] Univ Pavia, IRCCS, Policlin San Matteo, Div Cardiol, I-27100 Pavia, Italy
[3] Univ Pavia, IRCCS, Policlin San Matteo, Div Cardiac Surg, I-27100 Pavia, Italy
[4] Univ Pavia, IRCCS, Policlin San Matteo, Sci Adm, I-27100 Pavia, Italy
来源
NEPHRON | 2000年 / 84卷 / 01期
关键词
cardiac allograft recipients; renal function; heart transplantation; ciclosporin;
D O I
10.1159/000045534
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal dysfunction is one of the most common and threatening complications in heart transplant recipients. Even if ciclosporin seems to play a central role in inducing renal damage, other factors may concur or predispose to renal injury. In order to identify factors responsible for renal dysfunction, we retrospectively studied a cohort of 114 cardiac transplant recipients during a follow-up period of at least 3 years. The patients had a normal renal function before and 0.5 months after heart transplantation. Doubling of baseline serum creatinine or attainment of serum creatinine steadily above 176.8 mu mol/l (2.0 mg/dl) was used as criterion to define the end-point renal dysfunction. A series of clinical and laboratory variables were obtained from the patients' charts at different time intervals, and their prognostic value for the occurrence of renal dysfunction was calculated by Cox proportional hazards models. 23 out of 114 patients reached the end point after a median time period of 21 months. High serum triglyceride, alanine aminotransferase, alkaline phosphatase, ciclosporin, urea, glucose, and hemoglobin levels were shown to be associated with the development of renal dysfunction. Four variables, i.e., triglyceride, ciclosporin, urea, and alkaline phosphatase, had an independent prognostic value. Our results confirm a role for ciclosporin in inducing renal dysfunction and identify hyperlipidemia and an increased plasma urea level as risk factors for renal dysfunction in heart transplant recipients. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 50 条
  • [31] Male kidney allograft recipients at risk for urinary tract infection?
    Thoelking, Gerold
    Schuette-Nuetgen, Katharina
    Vogl, Thomas
    Dobrindt, Ulrich
    Kahl, Barbara C.
    Brand, Marcus
    Pavenstaedt, Hermann
    Suwelack, Barbara
    Koch, Raphael
    Reuter, Stefan
    PLOS ONE, 2017, 12 (11):
  • [32] Chronologically different impacts of immunologic and non-immunologic risk factors on renal allograft function
    Kim, MS
    Kim, DK
    Myoung, SM
    Kim, SI
    Oh, CK
    Kim, YS
    Lee, JH
    Kang, SW
    Park, K
    CLINICAL TRANSPLANTATION, 2005, 19 (06) : 742 - 750
  • [33] Pediatric Heart Transplant Recipients and Cardiac Allograft Vasculopathy The Importance of Hemodynamics
    Eisen, Howard J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (05) : 558 - 560
  • [34] RISK-FACTORS FOR DEVELOPMENT OF ACCELERATED CORONARY-ARTERY DISEASE IN CARDIAC TRANSPLANT RECIPIENTS
    RADOVANCEVIC, B
    POINDEXTER, S
    BIROVLJEV, S
    VELEBIT, V
    MCALLISTER, HA
    DUNCAN, JM
    VEGA, D
    LONQUIST, J
    BURNETT, CM
    FRAZIER, OH
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1990, 4 (06) : 309 - 313
  • [35] Factors affecting renal allograft survival in African Americans
    Gaston, RS
    BLOOD PURIFICATION, 1996, 14 (04) : 327 - 333
  • [36] Glomerular filtration rate: utility for assessing long-term renal allograft outcomes in kidney allograft recipients
    Marcen, Roberto
    Dal Canton, Antonio
    JOURNAL OF NEPHROLOGY, 2013, 26 (06) : 1009 - 1024
  • [37] Prevalence of Renal Dysfunction Among Pediatric Liver Transplant Recipients
    Basiratnia, Mitra
    Dehghani, Seyed Mohsen
    Razmjoee, Fatemeh
    Derakhshan, Dorna
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2020, 14 (02) : 145 - 152
  • [38] Visfatin serum concentration is associated with cardiac allograft vasculopathy in heart transplant recipients
    Szczurek, Wioletta
    Gasior, Mariusz
    Skrzypek, Michal
    Szygula-Jurkiewicz, Bozena
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (10) : 2857 - 2866
  • [39] Cardiac allograft vasculopathy: Differences in de novo and maintenance heart transplant recipients
    Frigerio, Maria
    Garascia, Andrea
    Roubina, Elena
    Distefano, Giada
    Orrego, Pedro Silva
    Colombo, Paola
    Bruschi, Giuseppe
    Vitali, Ettore
    TRANSPLANTATION, 2006, 82 (08) : S5 - S12